Doctor profile · Federal record
Dr. VARANT ARZOUMANIAN, MD
Hematology & Oncology Physician (CMS: HEMATOLOGY/ONCOLOGY) · Student in an Organized Health Care Education/Training Program · FORT SMITH, AR
- NPI 1790904027
- Accepts Medicare
- 30 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1001 TOWSON AVE, SUITE 300
FORT SMITH, AR 729014921
(479) 709-7435
fax (479) 709-7437 - Mailing address
-
PO BOX 11449
BELFAST, ME 049154005
Credentials & registration
- NPI registered
- April 2007 — 19 yrs on file
- Profile last updated
- November 23, 2016
- Year of graduation
- 1996 — 30 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Arkansas #E5432
- Medicaid (2)
- OK #200198270A · AR #171125001
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1790904027. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
4,728
Distinct HCPCS
10
Medicare allowed
$428,233
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,562 | 399 | $90 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 1,278 | 262 | $72 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 757 | 491 | $61 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 349 | 265 | $158 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 318 | 156 | $130 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 215 | 81 | $107 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 92 | 92 | $165 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 68 | 68 | $122 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 56 | 56 | $76 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 21 | 20 | $120 |
In context: peer comparison
Among 5 peers in this city , average services per provider: 238. This provider delivers 20× the peer median.Open Payments
Industry payments received
All-time total
$1,403
Transactions
79
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| PFIZER INC. | 21 | $245.87 | |
| AstraZeneca Pharmaceuticals LP | 11 | $188.71 | |
| Daiichi Sankyo Inc. | 8 | $180.85 | |
| Novartis Pharmaceuticals Corporation | 7 | $164.85 | |
| Gilead Sciences, Inc. | 6 | $98.45 | |
| GlaxoSmithKline, LLC. | 6 | $97.74 | |
| Rigel Pharmaceuticals, Inc. | 5 | $88.98 | |
| Merck Sharp & Dohme LLC | 3 | $65.79 | |
| ABBVIE INC. | 3 | $46.63 | |
| PUMA BIOTECHNOLOGY, INC. | 2 | $37.82 | |
| Janssen Biotech, Inc. | 2 | $35.62 | |
| Astellas Pharma US Inc | 2 | $34.89 | |
| Sumitomo Pharma America, Inc. | 1 | $25.65 | |
| RECORDATI_RARE_DISEASES_INC. | 1 | $23.49 | |
| Menarini Silicon Biosystems, Inc. | 1 | $19.79 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
3,567
Patients
977
Total drug cost
$187,589
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Letrozole | Generic | 516 | 110 | $10,598 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 396 | 97 | $12,375 |
| Ondansetron Hcl | Generic | 361 | 130 | $4,101 |
| Potassium Chloride | Generic | 277 | 86 | $4,318 |
| Prochlorperazine Maleate | Generic | 263 | 115 | $4,866 |
| Hydroxyurea | Generic | 213 | 38 | $6,410 |
| Tamoxifen Citrate | Generic | 202 | 42 | $4,900 |
| Eliquis (Apixaban) | Brand | 193 | 37 | $121,274 |
| Gabapentin | Generic | 191 | 53 | $2,916 |
| Alendronate Sodium | Generic | 184 | 39 | $1,550 |